IOVA icon

Iovance Biotherapeutics

173 hedge funds and large institutions have $2.25B invested in Iovance Biotherapeutics in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 23 closing their positions.

Holders
173
Holders Change
+6
Holders Change %
+3.59%
% of All Funds
3.8%
Holding in Top 10
8
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-33.33%
% of All Funds
0.18%
New
29
Increased
62
Reduced
57
Closed
23
Calls
$28.1M
Puts
$3.26M
Net Calls
+$24.9M
Net Calls Change
+$6.22M
Name Market Value Shares Shares
Change
Shares
Change %
EU
176
Emory University
Georgia
-131,041 Closed
DekaBank Deutsche Girozentrale
177
DekaBank Deutsche Girozentrale
Germany
-109,000 Closed
IBT
178
International Biotechnology Trust
United Kingdom
-104,000 Closed
HKAM
179
Horizon Kinetics Asset Management
New York
-28,076 Closed
SI
180
Shaker Investments
Ohio
-22,850 Closed
USAA
181
United Services Automobile Association
Texas
-18,390 Closed
Canada Life
182
Canada Life
Manitoba, Canada
-14,538 Closed
Group One Trading
183
Group One Trading
Illinois
-13,634 Closed
HighTower Advisors
184
HighTower Advisors
Illinois
-13,103 Closed
AG
185
Algert Global
California
-13,080 Closed
TCM
186
Towercrest Capital Management
Pennsylvania
-9,000 Closed
KAM
187
Kazazian Asset Management
Florida
-8,988 Closed
Prudential Financial
188
Prudential Financial
New Jersey
-8,640 Closed
AG
189
Aperio Group
California
-3,510 Closed
GAM
190
Griffin Asset Management
New York
-940 Closed
PHK
191
Point72 Hong Kong
Hong Kong
$0 27 -590 -96%
APC
192
Aspire Private Capital
North Carolina
-108 Closed
Parallax Volatility Advisers
193
Parallax Volatility Advisers
California
-10 Closed
CFD
194
Creative Financial Designs
Indiana
$0 9
CAC
195
Cowen and Company
New York
CG
196
Cutler Group
California
CFGS
197
Concourse Financial Group Securities
Alabama
HGWM
198
Harvest Group Wealth Management
Massachusetts
$0 1
GWS
199
Glassman Wealth Services
Virginia
$0 3 +3 New